$3.71
0.205.70%
At close: -
$3.69
-0.02-0.54%
After Hours: Feb 14, 5:59 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for BioLine Rx in recent months.
Browse guidance and forecast on all stocks.